corticosterone has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sezer, S | 1 |
| Bal, C | 1 |
| Kalem, AK | 1 |
| Kayaaslan, B | 1 |
| Eser, F | 1 |
| Hasanoglu, İ | 1 |
| Akıncı, E | 1 |
| Güner, R | 1 |
| Erel, Ö | 1 |
| Yılmaz, G | 1 |
| Szalanczy, AM | 1 |
| Giorgio, G | 1 |
| Goff, E | 1 |
| Seshie, O | 1 |
| Grzybowski, M | 1 |
| Klotz, J | 1 |
| Geurts, AM | 1 |
| Redei, EE | 1 |
| Solberg Woods, LC | 1 |
2 other studies available for corticosterone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
COVID-19 patients with altered steroid hormone levels are more likely to have higher disease severity.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Aldosterone; Androstenedione; Androstero | 2022 |
Changes in environmental stress over COVID-19 pandemic likely contributed to failure to replicate adiposity phenotype associated with
Topics: Adiposity; Animals; Communicable Disease Control; Corticosterone; COVID-19; Diet, High-Fat; Female; | 2023 |